ahlam1399
07-18-2016, 04:11 PM
China approves use of GSK vaccine Cervarix for cervical cancer
HONG KONG (Reuters) - Drugmaker GlaxoSmithKline Plc said on Monday the China Food and Drug Administration (CFDA) has approved its human papillomavirus (HPV) vaccine, Cervarix, for use in the country to help women fight cervical cancer.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=9doOV4GIvpY:q3ba8mcQeTo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=9doOV4GIvpY:q3ba8mcQeTo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=9doOV4GIvpY:q3ba8mcQeTo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=9doOV4GIvpY:q3ba8mcQeTo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=9doOV4GIvpY:q3ba8mcQeTo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/9doOV4GIvpY
HONG KONG (Reuters) - Drugmaker GlaxoSmithKline Plc said on Monday the China Food and Drug Administration (CFDA) has approved its human papillomavirus (HPV) vaccine, Cervarix, for use in the country to help women fight cervical cancer.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=9doOV4GIvpY:q3ba8mcQeTo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=9doOV4GIvpY:q3ba8mcQeTo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=9doOV4GIvpY:q3ba8mcQeTo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=9doOV4GIvpY:q3ba8mcQeTo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=9doOV4GIvpY:q3ba8mcQeTo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/9doOV4GIvpY